[Efficacy of combination of Ea-0643 (bunazosin hydrochloride) and bethanechol chloride in patients with neurogenic bladder]. 1990

T Araki, and S Nakano, and Y Sugimura, and H Tochigi, and J Kawamura, and T Kato, and K Tajima, and I Chigusa, and K Saito, and H Morisita
Department of Urology, Mie University School of Medicine.

Bethanechol chloride, a cholinergic agent and bunazosin hydrochloride, an alpha adrenergic blocking agent were administered orally to 28 patients with neurogenic bladder due to peripheral nerve disorders. To compare the effect of the two drugs, one of the drugs was initially administered orally for 2 weeks, and then both of them were administered for the next 2 weeks. Since there were some significant differences in the patient background between the two groups, it was difficult to compare the two drugs. However combined use of these drugs resulted in both objective and subjective good responses in those patients.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010277 Parasympathomimetics Drugs that mimic the effects of parasympathetic nervous system activity. Included here are drugs that directly stimulate muscarinic receptors and drugs that potentiate cholinergic activity, usually by slowing the breakdown of acetylcholine (CHOLINESTERASE INHIBITORS). Drugs that stimulate both sympathetic and parasympathetic postganglionic neurons (GANGLIONIC STIMULANTS) are not included here. Parasympathomimetic Agents,Parasympathomimetic Drugs,Parasympathomimetic Effect,Parasympathomimetic Effects,Agents, Parasympathomimetic,Drugs, Parasympathomimetic,Effect, Parasympathomimetic,Effects, Parasympathomimetic
D011799 Quinazolines A group of aromatic heterocyclic compounds that contain a bicyclic structure with two fused six-membered aromatic rings, a benzene ring and a pyrimidine ring. Quinazoline
D001750 Urinary Bladder, Neurogenic Dysfunction of the URINARY BLADDER due to disease of the central or peripheral nervous system pathways involved in the control of URINATION. This is often associated with SPINAL CORD DISEASES, but may also be caused by BRAIN DISEASES or PERIPHERAL NERVE DISEASES. Bladder Disorder, Neurogenic,Neurogenic Bladder,Bladder Neurogenesis,Bladder, Neurogenic,Neurogenic Bladder Disorder,Neurogenic Bladder, Atonic,Neurogenic Bladder, Spastic,Neurogenic Bladder, Uninhibited,Neurogenic Dysfunction of the Urinary Bladder,Neurogenic Urinary Bladder Disorder,Neurogenic Urinary Bladder, Atonic,Neurogenic Urinary Bladder, Spastic,Neurogenic Urinary Bladder, Uninhibited,Neuropathic Bladder,Urinary Bladder Disorder, Neurogenic,Urinary Bladder Neurogenesis,Urinary Bladder Neurogenic Dysfunction,Atonic Neurogenic Bladder,Neurogenesis, Bladder,Neurogenesis, Urinary Bladder,Neurogenic Bladder Disorders,Neurogenic Urinary Bladder,Spastic Neurogenic Bladder,Uninhibited Neurogenic Bladder
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000317 Adrenergic alpha-Antagonists Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. Adrenergic alpha-Receptor Blockaders,alpha-Adrenergic Blocking Agents,alpha-Adrenergic Receptor Blockaders,alpha-Blockers, Adrenergic,Adrenergic alpha-Blockers,alpha-Adrenergic Antagonists,alpha-Adrenergic Blockers,Adrenergic alpha Antagonists,Adrenergic alpha Blockers,Adrenergic alpha Receptor Blockaders,Agents, alpha-Adrenergic Blocking,Antagonists, alpha-Adrenergic,Blockaders, Adrenergic alpha-Receptor,Blockaders, alpha-Adrenergic Receptor,Blockers, alpha-Adrenergic,Blocking Agents, alpha-Adrenergic,Receptor Blockaders, alpha-Adrenergic,alpha Adrenergic Antagonists,alpha Adrenergic Blockers,alpha Adrenergic Blocking Agents,alpha Adrenergic Receptor Blockaders,alpha Blockers, Adrenergic,alpha-Antagonists, Adrenergic,alpha-Receptor Blockaders, Adrenergic

Related Publications

T Araki, and S Nakano, and Y Sugimura, and H Tochigi, and J Kawamura, and T Kato, and K Tajima, and I Chigusa, and K Saito, and H Morisita
December 1999, Drugs in R&D,
T Araki, and S Nakano, and Y Sugimura, and H Tochigi, and J Kawamura, and T Kato, and K Tajima, and I Chigusa, and K Saito, and H Morisita
November 1976, Urology,
T Araki, and S Nakano, and Y Sugimura, and H Tochigi, and J Kawamura, and T Kato, and K Tajima, and I Chigusa, and K Saito, and H Morisita
February 1992, Hinyokika kiyo. Acta urologica Japonica,
T Araki, and S Nakano, and Y Sugimura, and H Tochigi, and J Kawamura, and T Kato, and K Tajima, and I Chigusa, and K Saito, and H Morisita
October 1985, Hinyokika kiyo. Acta urologica Japonica,
T Araki, and S Nakano, and Y Sugimura, and H Tochigi, and J Kawamura, and T Kato, and K Tajima, and I Chigusa, and K Saito, and H Morisita
November 1979, The Journal of urology,
T Araki, and S Nakano, and Y Sugimura, and H Tochigi, and J Kawamura, and T Kato, and K Tajima, and I Chigusa, and K Saito, and H Morisita
October 1980, The Journal of urology,
T Araki, and S Nakano, and Y Sugimura, and H Tochigi, and J Kawamura, and T Kato, and K Tajima, and I Chigusa, and K Saito, and H Morisita
April 1980, The Journal of urology,
T Araki, and S Nakano, and Y Sugimura, and H Tochigi, and J Kawamura, and T Kato, and K Tajima, and I Chigusa, and K Saito, and H Morisita
September 1987, Hinyokika kiyo. Acta urologica Japonica,
T Araki, and S Nakano, and Y Sugimura, and H Tochigi, and J Kawamura, and T Kato, and K Tajima, and I Chigusa, and K Saito, and H Morisita
July 1982, The Journal of urology,
T Araki, and S Nakano, and Y Sugimura, and H Tochigi, and J Kawamura, and T Kato, and K Tajima, and I Chigusa, and K Saito, and H Morisita
October 1990, Hinyokika kiyo. Acta urologica Japonica,
Copied contents to your clipboard!